The German biotech ... Researchers shared the first look at OS data from the Chinese trial at the San Antonio Breast Cancer Symposium Tuesday.
News
- BioNTech's overall survival data show promise of potential Keytruda killer in breast cancer
- ALX Oncology Announces New Data Demonstrating Evorpacept in Combination with ... - Morningstar
Data from Phase 1b/2 clinical trial to be presented at 2024 San Antonio Breast Cancer Symposium (SABCS) show encouraging clinical activity in ...
- Bio-Techne Corp (TECH) Launches Innovative ESR1 Mutation Monitoring Assay
The assay will be featured at the San Antonio Breast Cancer Symposium, offering a highly sensitive detection method using qPCR technology. This ...
- UTSA's Stanton F. McHardy named fellow of National Academy of Inventors | UTSA Today
The CIDD is a collaborative initiative between UTSA and UT Health San Antonio. “I feel extremely honored to be included as an NAI fellow and have the ...
- Richmond-based BioAge sees stock fall over 70% after halting obesity drug clinical trial
San Antonio · San Francisco · Seattle · Silicon Valley · St. Louis · Tampa Bay ... Bay Area biotech sells cancer drug for over $400 million. Related ...